Literature DB >> 7644

Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes.

M Raiteri, F Angelini, A Bertollini.   

Abstract

The effects of mianserin, a tetracyclic antidepressant, on uptake and release of [3H]noradrenaline (3H-NA), [3H]dopamine (3H-DA), [3H]-5-hydroxytryptamine(3H-5-HT) and [3H]gamma-amino-butyric acid (3H-GABA) in synaptosomes from different areas of the rat brain were investigated in a comparative study with the tricyclic antidepressant imipramine. Mianserin and imipramine were inhibitors of 3H-NA uptake in the hypothalamus, but could not increase 3H-NA release from noradrenergic nerve endings. This behaviour was similar to that of (+)-amphetamine. Both mianserin and imipramine had essentially no effect on 3H-DA transport mechanisms in striatal synaptosomes. (+)-Amphetamine, in contrast, strongly affected both 3H-DA uptake and release. Imipramine was stronger than mianserin in inhibiting 3H-5-HT accumulation by striatal synaptosomes. In contrast, mianserin stimulated 3H-5-HT release whereas imipramine was ineffective. Mianserin had virtually no inhibitory activity on 3H-5-HT uptake by rat blood platelets. Imipramine was a modest inhibitor of 3H-GABA accumulation by whole brain synaptosomes; mianserin had no effect. Both drugs did not alter 3H-GABA release. These results indicate that mianserin interferes in a way different from that to tricyclic antidepressants with the neurotransmitter transport mechanisms at the presynaptic level.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 7644     DOI: 10.1111/j.2042-7158.1976.tb02770.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  13 in total

1.  A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake.

Authors:  B Harper; I E Hughes
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

2.  Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine.

Authors:  P A Baumann; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

3.  Effects of antidepressant agents on the synthesis of brain monoamines.

Authors:  A Carlsson; M Lindqvist
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

4.  The pharmacology of mianserin--an update.

Authors:  R J Marshall
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.

Authors:  I Goodlet; S E Mireylees; M F Sugrue
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

6.  Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin.

Authors:  H Schoemaker; H H Berendsen; H J Stevens; V J Nickolson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 7.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

8.  Interaction between mianserin and clonidine at alpha 2-adrenoceptors.

Authors:  Y Pommier; M Andréjak; P Mouillé; H Dabiré; B Lucet; H Schmitt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

9.  Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.

Authors:  A Randrup; C Braestrup
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

10.  Amitriptyline- and mianserin-induced changes in acquisition of paired-association learning-task.

Authors:  R Liljequist; T Seppälä; M J Mattila
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.